Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in PMVP — PMV Pharmaceuticals, Inc.

CIK 916542 Boston, MA
Back to PMVP Full portfolio

Position in PMVP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,969,297
+$221,589 QoQ
Shares Held
2,215,894
0.0% QoQ
Ownership
4.15%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 64 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PMVP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $732,389,014 across 168 Biotechnology names. PMVP ranks #34 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 1,664,999 $188,744,286
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,440 $98,170,137
3 IMCR
Immunocore Holdings plc
 1,209,894 $38,414,134
4 RIGL
Rigel Pharmaceuticals Inc
 591,686 $23,146,756
5 EXEL
Exelixis, Inc.
 421,444 $22,930,768
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,122 $20,923,261
7 TBPH
Theravance Biopharma, Inc.
 1,174,910 $19,973,470
8 PRTA
Prothena Corp Public Ltd Co
 2,010,645 $19,684,214

All Filings in PMVP

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,969,297 2,215,894
2026-03-31 $2,747,708 2,215,894
2025-12-31 $2,519,712 2,015,770
2025-09-30 $2,892,591 2,066,137
2025-06-30 $2,190,105 2,066,137
2025-03-31 $2,231,422 2,047,177
2024-12-31 $3,139,087 2,078,866
2024-09-30 $3,097,510 2,078,866
2024-06-30 $3,367,762 2,078,866
2024-03-31 $3,536,329 2,080,194
2023-12-31 $2,382,191 768,449